rg7201

Products Tofogliflozin was approved in Japan in 2014 (initial registration, Apleway, Deberza). The drug is not currently registered in many countries. Structure and properties Tofogliflozin (C22H26O6, Mr = 386.4 g/mol) Effects Tofogliflozin has antidiabetic and antihyperglycemic properties. It is a selective inhibitor of sodium–glucose co-transporter 2 (SGLT2). This transporter is responsible for the reabsorption of … Tofogliflozin